| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.51 | 0.02 |